Related Experiment Video
Updated: Jun 20, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway
Yannick Simonin1, Olivier Disson, Hervé Lerat
1Centre National de la Recherche Scientifique (CNRS), UMR 5535, Institut de Génétique Moléculaire de Montpellier, Montpellier, France.
Unlabelled:
An unresolved question regarding the physiopathology of hepatitis C virus (HCV) infection is the remarkable efficiency with which host defenses are neutralized to establish chronic infection. Modulation of an apoptotic response is one strategy used by viruses to escape immune surveillance. We previously showed that HCV proteins down-regulate expression of BH3-only Bcl2 interacting domain (Bid) in hepatocytes of HCV transgenic mice. As a consequence, cells acquire resistance to Fas-mediated apoptosis, which in turn leads to increased persistence of experimental viral infections in vivo. This mechanism might participate in the establishment of chronic infections and the resulting pathologies, including hepatocellular carcinoma. We now report that Bid is also down-regulated in patients in the context of noncirrhotic HCV-linked tumorigenesis and in the HCV RNA replicon system. We show that the nonstructural HCV viral protein NS5A is sufficient to activate a calpain cysteine protease, leading to degradation of Bid. Moreover, pharmacological inhibitors of calpains restore both the physiological levels of Bid and the sensitivity of cells toward a death receptor-mediated apoptotic signal. Finally, human HCV-related tumors and hepatocytes from HCV transgenic mice that display low Bid expression contain activated calpains.
Conclusion:
Calpains activated by HCV proteins degrade Bid and thus dampen apoptotic signaling. These results suggest that inhibiting calpains could lead to an improved efficiency of immune-mediated elimination of HCV-infected cells.
Insights
Hepatitis C virus (HCV) proteins activate calpains, which degrade Bid, a protein crucial for apoptosis. Inhibiting calpains may enhance the immune system's ability to clear HCV-infected cells.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Hepatitis C virus (HCV) establishes chronic infections by evading host defenses.
- Viruses often modulate apoptosis to escape immune surveillance.
- HCV proteins were previously shown to down-regulate Bid expression in mice, conferring resistance to apoptosis.
Purpose of the Study:
- To investigate the mechanism by which HCV down-regulates Bid expression in infected cells.
- To determine if this mechanism is relevant in human HCV infection and associated pathologies.
- To explore calpain inhibition as a therapeutic strategy.
Main Methods:
- Analysis of Bid expression in HCV patients and an HCV RNA replicon system.
- Investigating the role of HCV nonstructural protein NS5A in Bid degradation.
- Utilizing calpain inhibitors to restore Bid levels and apoptosis sensitivity.
- Assessing calpain activity in HCV-related tumors and infected mouse hepatocytes.
Main Results:
- Bid is down-regulated in noncirrhotic HCV-linked tumorigenesis and the HCV RNA replicon system.
- HCV nonstructural protein NS5A activates calpains, leading to Bid degradation.
- Calpain inhibitors restore Bid levels and Fas-mediated apoptosis sensitivity.
- Activated calpains are present in human HCV tumors and HCV transgenic mouse hepatocytes with low Bid.
Conclusions:
- HCV proteins activate calpains, which degrade Bid, thereby suppressing apoptotic signaling.
- This mechanism contributes to HCV persistence and pathogenesis, including hepatocellular carcinoma.
- Inhibiting calpains offers a potential strategy to enhance immune-mediated elimination of HCV-infected cells.
Related Concept Videos
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Caspases
Apoptosis
Hepatitis
Cirrhosis II: Pathophysiology
